Table 1.
Treatments linked to enduring sexual dysfunction
| Drug | Male | Female | Total (%) |
| Isotretinoin | 49 | 5 | 54 (18.0) |
| Escitalopram | 30 | 12 | 42 (14.0) |
| Citalopram | 29 | 12 | 41 (13.7) |
| Paroxetine | 36 | 4 | 40 (13.3) |
| Sertraline | 22 | 10 | 32 (10.7) |
| Fluoxetine | 24 | 7 | 31 (10.3) |
| Finasteride | 24 | 0 | 24 (8.0) |
| Venlafaxine | 16 | 3 | 19 (6.3) |
| Duloxetine | 8 | 2 | 10 (3.3) |
| Fluvoxamine | 2 | 0 | 2 (0.7) |
| Vortioxetine | 2 | 0 | 2 (0.7) |
| Clomipramine | 1 | 0 | 1 (0.3) |
| Desvenlafaxine | 1 | 0 | 1 (0.3) |
| Dutasteride | 1 | 0 | 1 (0.3) |